News Articles

Boehringer Ingelheim launches VAXXITEK® HVT+IBD+ND, a vaccine that protects poultry from three diseases

January 6, 2020

DULUTH, Ga. January 6, 2020 – Boehringer Ingelheim’s U.S. Animal Health Business launched a vaccine Monday to protect poultry from three diseases. VAXXITEK® HVT+IBD+ND provides a strong immune foundation and optimized protection against Marek’s Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease. Until now, Boehringer Ingelheim has offered two vaccines that guard against the…

Read More

Avanos Medical appoints new chief financial officer

December 30, 2019

Avanos Medical (NYSE:AVNS) today said it appointed Michael Greiner as senior VP and chief financial officer, effective Jan. 1. Greiner will be responsible for the Alpharetta, Ga.-based company’s global finance and information technology organizations. He will report to CEO Joe Woody. Prior to joining Avanos Medical, Greiner served as executive VP and CFO of AngioDynamics. He…

Read More

CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial

December 23, 2019

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) pursuant to an Investigational New Drug (IND) application to begin the PROACT Xa clinical trial, a prospective, randomized, trial to determine if patients with an On-X mechanical aortic…

Read More

Biotech company Dendreon extends metro Atlanta lease

December 18, 2019

Dendreon Pharmaceuticals has signed a 10-year lease agreement to maintain its 155,000-square-foot immunotherapy manufacturing facility in Union City, Ga. Dendreon is the maker of Provenge, an immunotherapy treatment for prostate cancer.  “Dendreon has been a proud member of the greater Atlanta community since 2009, and we are thrilled to extend our presence here,” said Christina Yi,…

Read More

Delta lands ‘long-term offtake agreement’ for advanced renewable biofuels

December 17, 2019

Delta is flying its green initiatives to the next level. Delta Air Lines Inc. (NYSE: DAL) said Tuesday it agreed to a “long-term offtake agreement” to purchase 10 million gallons annually of advanced renewable biofuels from Gevo Inc. (Nasdaq: GEVO). Delta said sustainable aviation fuels have a carbon footprint that can be up to 75%…

Read More

Biotech Leader Rachel King Explains Why Congress Should Reject H.R. 3 & Support Holistic Approach for Lowering Drug Costs

December 11, 2019

Rachel King, co-founder and CEO of GlycoMimetics, explains in a new video the important work her research team is doing to develop new treatments for patients with various diseases of the blood. Mrs. King explains why the U.S. leads the world in biomedical discovery and why Speaker Pelosi’s drug pricing plan (H.R. 3) would lead to fewer new treatments for patients.…

Read More